Join Medicilon at 2022 SOT Annual Meeting

2022’s SOT Annual Meeting is only a couple weeks away! Medicilon is excited to attend and exhibit at the conference. We are looking forward to finally seeing you in person. Our Vice President and US director of Business Development will be waiting at booth 1205. Please stop by and explore our preclinical testing services and capabilities!

This year, SOT Annual Meeting features a broad range of scientific sessions and a thematic program that provides participants with a unique opportunity to deepen their knowledge in topical areas and interact with leaders in their respective disciplines. Throughout the SOT Annual Meeting, the Society, Committees, Regional Chapters, Special Interest Groups, and Specialty Sections recognize distinguished toxicologists at every career level through hundreds of awards.

• Date: March 27-31, 2022

• Location: San Diego, California

• Booth: 1205

Medicilon Pharmacology & Toxicology Study

Medicilon owns professional teams and practical experiences in preclinical drug development. We are confident in providing high-quality data and short lead time to support a wide variety of drug safety evaluation studies with both GLP and non-GLP capabilities. Our research platform has been rated as Shanghai R&D Public Service Platform.

Medicilon Toxicology research service platforms

In addition to common administration routes such as PO and IV, the following characteristic evaluation platforms are also established:

• ❖Inhalation administration platform

• ❖Ophthalmic administration platform

• ❖Skin administration platform

• ❖Sublingual administration platform

• ❖Juvenile animal evaluation platform

• ❖An integrated evaluation technology platform for biological innovative drugs such as antibody, vaccine, ADC, CAR-T cell, and etc.